This is a limited company view. Sign up for a Free Trial to see everything.

Amicus Therapeutics is a global biotechnology company at the forefront of advanced therapies to treat a range of devastating rare and orphan diseases.

B2B
Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

New York

Founded

2002

Employees

342

Stage

Public

Total funding

$34M

Last funding

4 years ago

Acquisitions

2

Growth score

263

Mindshare score

54

Scoring

Deals

$15.0M Debt

Dec 3, 2013

$18.6M Venture

Jul 30, 2012

Employee Growth

Use Amicus Therapeutics's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Amicus Therapeutics's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

General Manager, Spain and Portugal
Commercial Director France
Key Account Manager - France South
Commercial Director
Clinical Project Manager
Regulatory Affairs Manager
Senior Director, Global Marketing
Associate Director, Drug Substance Development, Technical Operations
General Manager Norway
General Manager Sweden & Finland
Commercial Operations Manager
Director, Global Transparency
Senior Clinical Trial Manager
Sr. Director of Drug Safety
Country Manager Austria
General Manager
Director, Medical Writing
Associate Director Medical Affairs

Similar Companies

Innocrin Pharmaceuticals

Innocrin Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing small-molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers
Late|15 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes